Literature DB >> 27844107

Th9 cells in the pathogenesis of EAE and multiple sclerosis.

Wassim Elyaman1, Samia J Khoury2,3.   

Abstract

Interleukin (IL)-9 producing CD4+ T helper cells (Th9) are the newest addition to the T helper cell subsets. IL-9 binds to a heterodimeric receptor consisting of the IL-9 receptor (IL-9R) and a common γ chain also presents in IL-2, IL-4, IL-7, and IL-15 receptor complexes. In addition to Th9 cells, Th17 cells secrete smaller amounts of IL-9. Many functional and regulatory roles associated with Th9 cells are currently not fully understood. IL-9 is a pleiotropic cytokine that affects the activity of multiple cell types in the immune compartment as well as in the central nervous system (CNS). Initially implicated in type 2 inflammation, IL-9 has been recently shown to be a key player in regulating autoimmune responses in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Here, we review the current understanding of the role of Th9/IL-9 signaling in EAE and MS. We summarize the source and regulation of Th9 cells in vivo, the influence of IL-9 signaling on peripheral and CNS-resident cells in EAE, and the association between IL-9 and MS disease activity.

Entities:  

Keywords:  Autoimmunity; EAE; Immune regulation; Interleukin-9; Multiple sclerosis; T helper cells

Mesh:

Substances:

Year:  2016        PMID: 27844107     DOI: 10.1007/s00281-016-0604-y

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  76 in total

1.  Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.

Authors:  Xiuhua Yao; Qingfei Kong; Xiaoli Xie; Jinghua Wang; Na Li; Yumei Liu; Bo Sun; Ying Li; Guangyou Wang; Wenjin Li; Siying Qu; Haijun Zhao; Dandan Wang; Xijun Liu; Yao Zhang; Lili Mu; Hulun Li
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

2.  Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

Authors:  I Gramaglia; A D Weinberg; M Lemon; M Croft
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

3.  IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.

Authors:  Hongmei Li; Bardia Nourbakhsh; Melissa Cullimore; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Eur J Immunol       Date:  2011-07-06       Impact factor: 5.532

4.  OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells.

Authors:  P R Rogers; J Song; I Gramaglia; N Killeen; M Croft
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

5.  A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction.

Authors:  D M Muller; M P Pender; J M Greer
Journal:  Acta Neuropathol       Date:  2000-08       Impact factor: 17.088

6.  Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population.

Authors:  Hongmei Li; Bardia Nourbakhsh; Bogoljub Ciric; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

7.  IL-9 signaling affects central nervous system resident cells during inflammatory stimuli.

Authors:  Xiaoli Ding; Fang Cao; Langjun Cui; Bogoljub Ciric; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Exp Mol Pathol       Date:  2015-07-26       Impact factor: 3.362

8.  Interleukin-9 receptor alpha chain mRNA formation in CD8+ T cells producing anti-human immunodeficiency virus type 1 substance(s).

Authors:  M M Hossain; H Tsuchie; M A Detorio; H Shirono; C Hara; A Nishimoto; A Saji; J Koga; N Takata; J K Maniar; D G Saple; K Taniguchi; S Kageyama; H Ichimura; T Kurimura
Journal:  Acta Virol       Date:  1998-02       Impact factor: 1.162

9.  IL-9-induced expansion of B-1b cells restores numbers but not function of B-1 lymphocytes in xid mice.

Authors:  Laurent Knoops; Jamila Louahed; Jean-Christophe Renauld
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

10.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more
  23 in total

Review 1.  IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.

Authors:  Junhui Li; Shuqiu Chen; Xiang Xiao; Yong Zhao; Wenjun Ding; Xian C Li
Journal:  Cytokine Growth Factor Rev       Date:  2017-07-17       Impact factor: 7.638

Review 2.  Th9 cells in immunity and immunopathological diseases.

Authors:  Markus F Neurath; Mark H Kaplan
Journal:  Semin Immunopathol       Date:  2016-11-29       Impact factor: 9.623

3.  A novel multi-marker discovery approach identifies new serum biomarkers for Parkinson's disease in older people: an EXosomes in PArkiNson Disease (EXPAND) ancillary study.

Authors:  Riccardo Calvani; Anna Picca; Giovanni Landi; Federico Marini; Alessandra Biancolillo; Hélio José Coelho-Junior; Jacopo Gervasoni; Silvia Persichilli; Aniello Primiano; Annalaura Arcidiacono; Andrea Urbani; Maurizio Bossola; Anna Rita Bentivoglio; Matteo Cesari; Roberto Bernabei; Maria Rita Lo Monaco; Emanuele Marzetti
Journal:  Geroscience       Date:  2020-05-26       Impact factor: 7.713

4.  Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease.

Authors:  Keri Csencsits-Smith; Jessika Suescun; Kan Li; Sheng Luo; Diane L Bick; Mya Schiess
Journal:  Neuroimmunomodulation       Date:  2017-04-11       Impact factor: 2.492

5.  Effect of crosstalk between Th17 and Th9 cells on the activation of dermal vascular smooth muscle cells in systemic scleroderma and regulation of tanshinone IIA.

Authors:  Mengguo Liu
Journal:  An Bras Dermatol       Date:  2022-09-15       Impact factor: 2.113

6.  Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis.

Authors:  Antonio Bruno; Ettore Dolcetti; Federica Azzolini; Alessandro Moscatelli; Stefano Gambardella; Rosangela Ferese; Francesca Romana Rizzo; Luana Gilio; Ennio Iezzi; Giovanni Galifi; Angela Borrelli; Fabio Buttari; Roberto Furlan; Annamaria Finardi; Francesca De Vito; Alessandra Musella; Livia Guadalupi; Georgia Mandolesi; Diego Centonze; Mario Stampanoni Bassi
Journal:  Genes (Basel)       Date:  2022-05-17       Impact factor: 4.141

7.  NFIL3 deficiency alleviates EAE through regulating different immune cell subsets.

Authors:  Zhigang Chen; Rong Fan; Jie Liang; Zexiu Xiao; Junlong Dang; Jun Zhao; Ruihui Weng; Cansheng Zhu; Song Guo Zheng; Ying Jiang
Journal:  J Adv Res       Date:  2021-11-14       Impact factor: 12.822

8.  IL-9-triggered lncRNA Gm13568 regulates Notch1 in astrocytes through interaction with CBP/P300: contribute to the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Xiaomei Liu; Feng Zhou; Weixiao Wang; Guofang Chen; Qingxiu Zhang; Ruixue Lv; Zijun Zhao; Xiangyang Li; Qian Yu; Jessica M Meves; Hui Hua; Xiaocui Li; Xiaotian Wang; Hong Sun; Dianshuai Gao
Journal:  J Neuroinflammation       Date:  2021-05-11       Impact factor: 8.322

9.  Do TRIB1 and IL-9 Gene Polymorphisms Impact the Development and Manifestation of Pituitary Adenoma?

Authors:  Tomas Mickevicius; Alvita Vilkeviciute; Brigita Glebauskiene; Loresa Kriauciuniene; Rasa Liutkeviciene
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

10.  Foxo1 Promotes Th9 Cell Differentiation and Airway Allergy.

Authors:  Thomas S Buttrick; Wei Wang; Christina Yung; Kenneth G Trieu; Kruti Patel; Samia J Khoury; Xingbin Ai; Wassim Elyaman
Journal:  Sci Rep       Date:  2018-01-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.